CD8A and neoplasm: These nanoparticles improve intracellular drug delivery, synergistically inhibit tumor growth, and enhance survival in lung cancer models by modulating immune responses, increasing CD4+ and CD8+ T cells, reducing Treg cells, and activating cytokine production(Fig. 5) [106].